The Trump administration has cut around 100 employees, or roughly 10%, of the federal agency that oversees mental and ...

The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...

COVID-19 took the lives of more than one million Americans and nearly 116,000 Californians, according to the Centers for Disease Control and Prevention.

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

Bridgette J. Picou, LVN, ACLPN, presented research on the lived experiences of women living with HIV and going through ...

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

HIV incidence in sub-Saharan Africa has declined substantially, according to both UNAIDS estimates and empirical data pulled ...

Five years ago, the World Health Organization declared Covid a global pandemic, but many people are still living with the ...

Pre-exposure prophylaxis (PrEP) is the advent of antiretroviral treatment use for people at increased risk of acquiring HIV-1 ...

Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...

The measles outbreak in the South Plains region of Texas has grown to 223 cases. 29 of those infected have been hospitalized ...